Search

everythinglearnresearchcommunity

for

Search:↓

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

CEC levels may be a useful marker for predicting prostate cancer progression.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Gut bacteria can lower androgen levels in male mice.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Gene variation affects prostate issues and hair loss.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.